Surfactant therapy in preterm infants with respiratory distress syndrome and in near-term or term newborns with acute RDS

Por Ramanathan, R
Publicado no J Perinatol (2006)

Blood cultures in neonates with percutaneous central venous catheters.

Por Ramanathan, R, Durand, M
Publicado em 1987

Intestinal fatty acid binding protein: a specific residue in one turn appears to stabilize the native structure and be responsible for slow refolding.

Por Kim, K., Ramanathan, R., Frieden, C.
Publicado em 1997

Proximal Tibia Bone Graft: An alternative Donor Source especially for Foot and Ankle Procedures

Por Jia, TY, Gurmeet, S, Asni, A, Ramanathan, R
Publicado no Malays Orthop J (2015)

Knowledge Gaps Persist and Hinder Progress in Eliminating Mumps

Por Ramanathan, R, Voigt, EA, Kennedy, RB, Poland, GA
Publicado no Vaccine (2018)

Effect of cell substrate on antioxidant enzyme activities in cultured renal glomerular epithelium.

Por Yang, A. H., Oberley, T. D., Oberley, L. W., Ramanathan, R.
Publicado em 1988

Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study

Por Ramanathan, R, Bhatia, J J, Sekar, K, Ernst, F R
Publicado em 2013

A New Transformation-Deficient Mutant of Haemophilus influenzae Rd with Normal DNA Uptake

Por Gwinn, M. L., Ramanathan, R., Smith, H. O., Tomb, J.-F.
Publicado em 1998

Biophysical characterization of small molecule antiviral-loaded nanolipogels for HIV-1 chemoprophylaxis and topical mucosal application

Por Ramanathan, R., Jiang, Y., Read, B., Golan-Paz, S., Woodrow, K.A.
Publicado no Acta Biomater (2016)

Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline

Por Ramanathan, R. K., Korn, R. L., Chiorean, E. G., Liu, H., Von Hoff, D. D.
Publicado no Ann Oncol (2016)

PD-010 Association between chemotherapy-induced neutropenia at 1-month and overall survival in patients receiving TAS-102 for metastatic colorectal cancer

Por Kotani, D., Pashtoon, K., Cecchini, M., Shitara, K., Ohtsu, A., Ramanathan, R., Hochster, H., Grothey, A., Yoshino, T.
Publicado no Ann Oncol (2016)

Effect of mucosal cytokine administration on selective expansion of vaginal dendritic cells to support nanoparticle transport

Por Ramanathan, R., Park, J., Hughes, S.M., Lykins, W.R., Bennett, H.R., Hladik, F., Woodrow, K.A.
Publicado no Am J Reprod Immunol (2015)

Improving the lean muscle color of dark-cutting beef by aging, antioxidant-enhancement, and modified atmospheric packaging

Por Wills, K. M., Mitacek, R. M., Mafi, G. G., VanOverbeke, D. L., Jaroni, D., Jadeja, R., Ramanathan, R.
Publicado no J Anim Sci (2017)

A randomized phase II of gemcitabine and sorafenib versus sorafenib alone in patients with metastatic pancreatic cancer

Por El-Khoueiry, A. B., Ramanathan, R. K., Yang, D. Y., Zhang, W., Shibata, S., Wright, J. J., Gandara, D., Lenz, H. J.
Publicado em 2011

Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT

Por Hochster, H. S., Grothey, A., Hart, L., Rowland, K., Ansari, R., Alberts, S., Chowhan, N., Ramanathan, R. K., Keaton, M., Hainsworth, J. D., Childs, B. H.
Publicado em 2014

Phase I ficlatuzumab monotherapy or with erlotinib for refractory advanced solid tumours and multiple myeloma

Por Patnaik, A, Weiss, G J, Papadopoulos, K P, Hofmeister, C C, Tibes, R, Tolcher, A, Isaacs, R, Jac, J, Han, M, Payumo, F C, Cotreau, M M, Ramanathan, R K
Publicado em 2014

Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic a...

Por Ramanathan, R. K., Goldstein, D., Korn, R. L., Arena, F., Moore, M., Siena, S., Teixeira, L., Tabernero, J., Van Laethem, J.-L., Liu, H., McGovern, D., Lu, B., Von Hoff, D. D.
Publicado no Ann Oncol (2016)

Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators

Por Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., Cerny, R. L., Rogan, E. G.
Publicado em 1997

Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies

Por Mahadevan, D., Chiorean, E.G., Harris, W.B., Von Hoff, D.D., Stejskal-Barnett, A., Qi, W., Anthony, S.P., Younger, A.E., Rensvold, D.M., Cordova, F., Shelton, C.F., Becker, M.D., Garlich, J.R., Durden, D.L., Ramanathan, R.K.
Publicado em 2012

PD-011 Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5...

Por Mahalingam, D., Patel, M., Sachdev, J., Hart, L., Halama, N., Ramanathan, R., Sarantopoulos, J., Liu, X., Yazji, S., Jäger, D., Adib, D., Kerschbaumer, R., Yoon, M., Manzur, G., Starodub, A., Sivarajan, K., Wertheim, M., Thambi, P., Jones, M., Goel, S., Nemunaitis, J., Tsimberidou, A.
Publicado no Ann Oncol (2016)